SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-127553
Filing Date
2022-04-28
Accepted
2022-04-28 16:09:48
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A d425983ddefa14a.htm DEFA14A 30534
2 GRAPHIC g425983g89g56.jpg GRAPHIC 6031
3 GRAPHIC g425983g89g57.jpg GRAPHIC 40817
4 GRAPHIC g425983g89g58.jpg GRAPHIC 111461
5 GRAPHIC g425983g89g59.jpg GRAPHIC 1769
  Complete submission text file 0001193125-22-127553.txt   252540
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37539 | Film No.: 22866592
SIC: 2834 Pharmaceutical Preparations